Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir
- Status
- COMPLETED
- Phase
- PHASE4
Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
- Status
- COMPLETED
- Phase
- PHASE3
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
- Status
- TERMINATED
- Phase
- NA
Angina Prevalence and Provider Evaluation of Angina Relief
- Status
- COMPLETED
- Phase
- N/A
Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV
- Status
- COMPLETED
- Phase
- PHASE3
Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients
- Status
- UNKNOWN
- Phase
- N/A
Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
- Status
- COMPLETED
- Phase
- PHASE2
Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine
- Status
- TERMINATED
- Phase
- PHASE1
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
- Status
- TERMINATED
- Phase
- PHASE2
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
- Status
- COMPLETED
- Phase
- PHASE3